MSST.F Stock Overview
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Mindset Pharma Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.54 |
| 52 Week High | CA$0.56 |
| 52 Week Low | CA$0.16 |
| Beta | -0.098 |
| 11 Month Change | -0.96% |
| 3 Month Change | 39.94% |
| 1 Year Change | 59.43% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -39.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| MSST.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0.5% | -5.3% | -1.2% |
| 1Y | 59.4% | 8.7% | 30.4% |
Return vs Industry: MSST.F exceeded the US Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: MSST.F exceeded the US Market which returned 15.2% over the past year.
Price Volatility
| MSST.F volatility | |
|---|---|
| MSST.F Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 9.4% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MSST.F's share price has been volatile over the past 3 months.
Volatility Over Time: MSST.F's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | James Lanthier | www.mindsetpharma.com |
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
Mindset Pharma Inc. Fundamentals Summary
| MSST.F fundamental statistics | |
|---|---|
| Market cap | US$54.04m |
| Earnings (TTM) | -US$4.40m |
| Revenue (TTM) | US$5.59m |
9.7x
P/S Ratio-12.3x
P/E RatioIs MSST.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MSST.F income statement (TTM) | |
|---|---|
| Revenue | CA$7.75m |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$7.75m |
| Other Expenses | CA$13.86m |
| Earnings | -CA$6.11m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.06 |
| Gross Margin | 100.00% |
| Net Profit Margin | -78.82% |
| Debt/Equity Ratio | 0% |
How did MSST.F perform over the long term?
See historical performance and comparison